www.uhasselt.be
DSpace

Document Server@UHasselt >
Research >
Research publications >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/21836

Title: REVEALING AND ACKNOWLEDGING VALUE JUDGMENTS IN HEALTH TECHNOLOGY ASSESSMENT
Authors: Hofmann, Bjorn
Cleemput, Irina
Bond, Kenneth
Krones, Tanja
Droste, Sigrid
Sacchini, Dario
Oortwijn, Wija
Issue Date: 2014
Publisher: CAMBRIDGE UNIV PRESS
Citation: INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 30 (6), p. 579-586
Abstract: Background: Although value issues are increasingly addressed in health technology assessment (HTA) reports, HTA is still seen as a scientific endeavor and sometimes contrasted with value judgments, which are considered arbitrary and unscientific. This article aims at illustrating how numerous value judgments are at play in the HTA process, and why it is important to acknowledge and address value judgments. Methods: A panel of experts involved in HTA, including ethicists, scrutinized the HTA process with regard to implicit value judgments. It was analyzed whether these value judgments undermine the accountability of HTA results. The final results were obtained after several rounds of deliberation. Results: Value judgments are identified before the assessment when identifying and selecting health technologies to assess, and as part of assessment. They are at play in the processes of deciding on how to select, frame, present, summarize or synthesize information in systematic reviews. Also, in economic analysis, value judgments are ubiquitous. Addressing the ethical, legal, and social issues of a given health technology involves moral, legal, and social value judgments by definition. So do the appraisal and the decision-making process. Conclusions: HTA by and large is a process of value judgments. However, the preponderance of value judgments does not render HTA biased or flawed. On the contrary they are basic elements of the HTA process. Acknowledging and explicitly addressing value judgments may improve the accountability of HTA.
Notes: [Hofmann, Bjorn] Univ Coll Gjovik, N-2802 Gjovik, Norway. [Hofmann, Bjorn] Univ Oslo, N-0316 Oslo, Norway. [Cleemput, Irina] Hasselt Univ, Brussels, Belgium. [Cleemput, Irina] Belgian Hlth Care Knowledge Ctr KCE, Brussels, Belgium. [Bond, Kenneth] Canadian Agcy Drugs & Technol Hlth, Strateg Initiat, Ottawa, ON K1S 5S8, Canada. [Krones, Tanja] Univ Zurich, Univ Hosp, Inst Biomed Eth & Hist, CH-8006 Zurich, Switzerland. [Droste, Sigrid] Inst Qual & Efficiency Healthcare IQWiG, Dept Qual Healthcare, D-50670 Cologne, Germany. [Sacchini, Dario] Univ Cattolica Sacro Cuore, Agostino Gemelli Sch Med, Inst Bioeth, Rome, Italy. [Oortwijn, Wija] Ecorys Netherlands, Rotterdam, Netherlands.
URI: http://hdl.handle.net/1942/21836
DOI: 10.1017/S0266462314000671
ISI #: 000356142100003
ISSN: 0266-4623
Category: A1
Type: Journal Contribution
Validation: ecoom, 2016
Appears in Collections: Research publications

Files in This Item:

Description SizeFormat
published version149.25 kBAdobe PDF

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.